09:54 AM EST - Numinus Wellness Inc. : Announces that Health Canada has approved the Company's Clinical Trial Application to examine the feasibility of a group model in MDMA-assisted psychotherapy enrolling trainee practitioners as participants. Numinus Wellness Inc.
shares T.NUMI are trading unchanged at $0.07.
